Moin Vera is a Rare/Genetic physician affiliated with Kaiser Permanente. OpenAlex indexes 20 publications with 316 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4650 W Sunset Blvd
Los Angeles, CA 900276062
Telephone
323-660-2450Registry record last updated 1 Dec 2021.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BioMarin Pharmaceutical Inc.Program year20211 payment
- Travere Therapeutics, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Bile Acid100%Chenodal100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes
The American Journal of Human Genetics
2024 - Combining angiotensin receptor blockade and enzyme replacement therapy for vascular disease in mucopolysaccharidosis type I
Molecular Genetics and Metabolism Reports
2023 - m.3685T>C is a Novel Mitochondrial DNA Variant That Causes Leigh Syndrome
Molecular Case Studies
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Shalin Pandya, DO
Kaiser Permanente
Susy Peng, MD
Kaiser Permanente
Prasanth Manthena, MD
Kaiser Permanente
Alan Go, MD
Kaiser Permanente
Ronald Wapner, MD
Columbia University Irving Medical Center
Virginia Kimonis, MD
UC Irvine School of Medicine
Robert Hopkin, MD
Cincinnati Children's Hospital Medical Center
Nicola Longo, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”